Product(s)

We like to invest in product development projects; we will rarely invest in services. Products in clinical or preclinical development should have an attractive market potential or, if a niche indication is targeted, its potential market share should be significant and realistic. Ideally, we would like to invest in companies that have a platform technology capable of generating new product candidates on a sustainable basis with a competitive advantage.